News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MonoSolRx LLC and BiondVax Pharmaceuticals Collaborate to Develop Oral Film Delivery of Flu Vaccine


11/7/2012 9:25:05 AM

WARREN, N.J., Nov. 7, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, announced today that it has entered into a partnership with BiondVax, an Israeli based pharmaceutical company, to develop an oral film formulation of BiondVax' universal flu vaccine, M-001, utilizing MonoSol Rx's PharmFilm® delivery platform. There are significant advantages for this needle free delivery in vaccines, including ease of use, increased compliance and simplified distribution.

Read at GlobeNewswire

comments powered by Disqus
   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES